Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Auditor change
|
|
Viridian Therapeutics, Inc. (MGEN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| Harwin Peter Evan (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 20,000 options to buy
@ $27.67, valued at
$553.4k
|
|
| 06/16/2023 |
4
| Moses Jennifer K. (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 20,000 options to buy
@ $27.67, valued at
$553.4k
|
|
| 06/16/2023 |
4
| Kiselak Tomas (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 20,000 options to buy
@ $27.67, valued at
$553.4k
|
|
| 06/16/2023 |
4
| Morris Arlene (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 20,000 options to buy
@ $27.67, valued at
$553.4k
|
|
| 06/06/2023 |
4
| Meisner Lara (Chief Legal Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 1,875 shares
@ $24.21, valued at
$45.4k
Sold 499 shares
@ $25.03, valued at
$12.5k
Sold 5,126 shares
@ $25.02, valued at
$128.3k
Exercised 1,875 options to buy
@ $14, valued at
$26.3k
Exercised 499 options to buy
@ $18.51, valued at
$9.2k
Exercised 5,126 options to buy
@ $18.51, valued at
$94.9k
|
|
| 03/13/2023 |
4
| Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Bought 5,500 shares
@ $29.1499, valued at
$160.3k
|
|
| 03/10/2023 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 29,971 shares
@ $29.07, valued at
$871.3k
|
|
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2023 |
4
| Myers Scott Dunseth (CEO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 250,000 shares
@ $0
Granted 1,000,000 options to buy
@ $35.8, valued at
$35.8M
|
|
| 02/03/2023 |
4
| Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 50,000 shares
@ $36.8, valued at
$1.8M
|
|
| 01/25/2023 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 6,843 shares
@ $35.66, valued at
$244k
Exercised 4,971 options to buy
@ $23.03, valued at
$114.5k
Exercised 1,872 options to buy
@ $14, valued at
$26.2k
|
|
| 01/18/2023 |
4
| Katz Barrett (Chief Medical Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 4,147 shares
@ $37.01, valued at
$153.5k
Sold 24,853 shares
@ $37.21, valued at
$924.8k
Exercised 4,147 options to buy
@ $23.03, valued at
$95.5k
Exercised 24,853 options to buy
@ $23.03, valued at
$572.4k
|
|
| 01/11/2023 |
4
| Katz Barrett (Chief Medical Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 12,623 shares
@ $33.04, valued at
$417.1k
Sold 47,377 shares
@ $35.3, valued at
$1.7M
Exercised 12,623 options to buy
@ $23.03, valued at
$290.7k
Exercised 47,377 options to buy
@ $23.03, valued at
$1.1M
|
|
| 12/22/2022 |
4
| Meisner Lara (General Counsel and Secretary) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 600 shares
@ $28.07, valued at
$16.8k
Sold 16,326 shares
@ $29.19, valued at
$476.6k
Exercised 600 options to buy
@ $23.03, valued at
$13.8k
Exercised 16,326 options to buy
@ $23.03, valued at
$376k
|
|
| 12/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2022 |
4
| Fairmount Funds Management LLC (10% Owner) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Bought 425,531 shares
@ $23.5, valued at
$10M
|
|
| 06/10/2022 |
4
| Moses Jennifer K. (Director) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 12,500 options to buy
@ $12.31, valued at
$153.9k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 30,000 shares
@ $12.2, valued at
$366k
|
|
| 05/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/05/2022 |
4
| Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 26,400 shares
@ $18.92, valued at
$499.5k
Sold 3,600 shares
@ $18.93, valued at
$68.1k
|
|
| 03/03/2022 |
4
| Violin Jonathan (Chief Executive Officer) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Sold 18,894 shares
@ $17.82, valued at
$336.7k
Sold 11,106 shares
@ $17.36, valued at
$192.8k
|
|
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2022 |
4
| Humer Kristian (CFO and CBO) has filed a Form 4 on Viridian Therapeutics, Inc.\DE|
Txns:
| Granted 121,371 options to buy
@ $19.77, valued at
$2.4M
|
|
|
|
|